| 标题 |
 EPIK-B5: A phase III, randomized study of alpelisib (ALP) plus fulvestrant (FUL) in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated advanced breast cancer (ABC) progressing on/after an aromatase inhibitor (AI) with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Clinical Oncology 作者：Michelino De Laurentiis; Luis Costa; Joseph Gligorov; Ann Knop; Elzbieta Senkus-Konefka; et al 出版日期：2022 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
null
秋风
周周
DW
吃葡萄不吐葡萄皮
Magic
OK
v0id
简单
机智的白卉
Criminology34
牧青
初景
aaaa
sagitar
GingerF
果果123
学术雷锋
tao
皖公网安备34019202002308
